Protocol Ledger

NCT05200260 · Phase II · RECRUITING

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Interventional Phase II clinical trial protocol NCT05200260 sponsored by Shanghai Gynecologic Oncology Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-07-13 Enrollment: 220 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05200260
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)220 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05200260
Protocol FieldVerified Registry Value
NCT IdentifierNCT05200260
Consolidated Lead SponsorShanghai Gynecologic Oncology Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment220 participants (ESTIMATED)
Registered Start Date2022-07-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05200260
Hospital Research SiteLocationSite Profile
The First Affiliated Hospital, Zhejiang University School of MedicineHangzhou, ChinaOpen Hospital Dossier ->
Zhejiang Cancer HospitalHangzhou, ChinaOpen Hospital Dossier ->
Zhongshan Hospital Fudan UniversityShanghai, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI